Study of TFX06 in Women With Advanced Breast Cancer.
Clinical trial NCT05927779 · UNKNOWN
Trial details
- NCT number
- NCT05927779
- Sponsor
- Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2024-12-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.